Rapport Therapeutics Inc. Common Stock (RAPP) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Rapport Therapeutics Inc....

    NASDAQ: RAPP · Real-Time Price · USD
    28.54
    0.00 (0.00%)
    At close: Oct 03, 2025, 3:59 PM
    29.00
    1.61%
    Pre-market: Oct 06, 2025, 05:51 AM EDT

    Rapport Therapeutics Common Stock Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
    Net Income
    		 -88.31M -79.7M -78.31M -71.85M -63.02M -51.31M -34.79M -21.27M -12.56M -6.15M
    Depreciation & Amortization
    		 975K 931K 839K 632K 436K 249K 112K 59K 36K 15K
    Stock-Based Compensation
    		 14.82M 12.78M 10.23M 8.03M 5.7M 4.29M 3.52M 2.53M 1.67M 723K
    Other Working Capital
    		 -1.09M 3.09M 1.69M 2.21M 630K -307K 1.29M 75K -1.58M -422K
    Other Non-Cash Items
    		 -4.47M -5.53M 1.06M 506K 6.18M 7.84M 3.06M 2.89M 2.77M 1.78M
    Deferred Income Tax
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Change in Working Capital
    		 818K 4.07M 1.34M 1.94M 948K -83K 2.65M 708K -1.58M -422K
    Operating Cash Flow
    		 -76.17M -67.45M -64.83M -60.74M -49.75M -39.99M -27.18M -16.82M -11.4M -4.8M
    Capital Expenditures
    		 -679K -1.62M -2.4M -3.62M -3.53M -2.65M -1.64M -199K -147K -61K
    Cash Acquisitions
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Purchase of Investments
    		 -254.69M -380.17M -381.3M -373.97M -260.45M -122.03M -77.22M n/a n/a n/a
    Sales Maturities Of Investments
    		 273.59M 270.41M 209.8M 93.08M 36.24M 3.95M n/a n/a n/a n/a
    Other Investing Acitivies
    		 4.3M 4.21M 3.77M 3.77M n/a n/a n/a n/a n/a n/a
    Investing Cash Flow
    		 22.52M -107.18M -170.14M -280.73M -227.74M -120.72M -78.86M -199K -147K -61K
    Debt Repayment
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Common Stock Repurchased
    		 -1K -1K n/a n/a -4K -4K -4K -4K n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 221.63M 221.91M 221.63M -134K -76K -399K -134K n/a -58K -18K
    Financial Cash Flow
    		 -1.45M 157.97M 221.63M 221.48M 308.23M 148.79M 145.14M 145.28M 59.92M 60.01M
    Net Cash Flow
    		 -55.1M -16.66M -13.34M -119.99M 30.74M -11.93M 39.09M 128.25M 48.37M 55.14M
    Free Cash Flow
    		 -76.85M -69.07M -67.23M -64.36M -53.28M -42.64M -28.82M -17.02M -11.55M -4.86M

    Add to Watchlist